MSHGCL:Multi-Scale Hierarchical Graph Contrastive Learning for Drug-Drug Interactions

  • Daohui Ge
  • , Xueyan Song
  • , Guangshun Zhang
  • , Jiaying Yan
  • , Jiahao Li
  • , Jin Xing Liu

Research output: Contribution to journalArticlepeer-review

Abstract

Drug–drug interactions (DDIs) refer to the change in efficacy when two or more drugs taken at the same time. Reasonable DDI can enhance efficacy or reduce adverse drug reactions; otherwise, it may lead to adverse events. The recent DDI prediction methods, which use different graph neural networks to extract the drug substructures, convert the DDI prediction into the prediction of the relationship between the two drug substructures, and achieve good performance. However, these methods do not pay attention to the relationship between drug substructures extracted from the same drug. Therefore, we propose MSHGCL to constrain the relationship between drug substructures by multi-scale hierarchical graph contrastive learning module. Specifically, the intra-layer contrastive learning module constrains the relationship between drug substructures of the same scale, and the inter-layer contrastive learning module further constrains the relationship between drug substructures of adjacent layers. We evaluate MSHGCL on two real-world datasets. Experimental results show that the proposed MSHGCL method outperforms the most advanced DDI prediction method.

Original languageEnglish
JournalIEEE Journal of Biomedical and Health Informatics
DOIs
StateAccepted/In press - 2025

Keywords

  • Contrastive Learning
  • Deep Learning
  • Drug Substructure
  • Drug–Drug Interactions
  • Graph Neural Network

Fingerprint

Dive into the research topics of 'MSHGCL:Multi-Scale Hierarchical Graph Contrastive Learning for Drug-Drug Interactions'. Together they form a unique fingerprint.

Cite this